Contact Us

TOURISM NEWS

Cellid Unveils Cutting-Edge AR Glasses at CES 2025, Revolutionizing Everyday AR Experiences

Dec 18, 2024

Reference Design of Japanese-made,eyeglass-type lightweight AR glasses unveiled TOKYO,Dec. 17,2024-- Cellid Inc.,a developer of AR glasses displays and spatial recognition engines for next-generation

NEXCOM Shows the Power of Cost-Efficient Cryptography Performance

Dec 18, 2024

TAIPEI,Dec. 18,2024-- NEXCOM,a leading supplier of network solutions,has introduced a new generation of cybersecurity uCPEs powered by Intel® architecture CPUs. Designed as cost-efficient yet high

HoSkar Night Event Series 2025: Let's explore the Real Estate market together!

Dec 18, 2024

HO CHI MINH CITY,Vietnam,Dec. 18,2024-- TheHoSkar Night series has become a favorite event for hospitality and real estate professionals across Asia,connecting industry leaders,developers,and innovato

Wondershare Unveils Recoverit 13.5: Introducing Enhanced Compatibility and More Efficient Data Recovery Solutions

Dec 18, 2024

VANCOUVER,BC,Dec. 18,2024-- Wondershare,a global leader in innovative software solutions,proudly announces the launch of Recoverit 13.5,the latest iteration of its flagship data recovery software. The

SUSTAINABILITY ENVIRONMENT ASIA CONCLUDES SUCCESSFULLY

Dec 18, 2024

Highlighting New Trends and Driving Growth Prospects KUALA LUMPUR,Malaysia,Dec. 18,2024-- The 2nd Sustainability Environment Asia (SEA) exhibition and conference concluded successfully at the Kuala Lu

U.S. FDA approves Celltrion's STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab)

Dec 18, 2024

STEQEYMA (CT-P43) is approved for both adult and pediatric patients with plaque psoriasis (PsO) and active psoriatic arthritis (PsA) as well as adults with Crohn\'s disease (CD) and ulcerative coliti

1 ... 191 192 193 194 195 196 197 ... 372